Skip to main content

Vol. 2026 · Bill Detail · Special Edition

CivicRadar.

Wednesday, September 2, 2026

Free · Stays on your device

MO · HB2081INTRO · 1 COSPONSOR

Creates provisions relating to reporting requirements for entities that participate in the 340B drug pricing program

Where it is in the process
Plain-English Summary

This bill creates new reporting requirements for entities in Missouri that participate in the federal 340B Drug Pricing Program. These entities would need to report detailed financial and operational information about their 340B program to the Department of Health and Senior Services annually. The department would then create an aggregated report for the general assembly and post it online, while individual entity data would remain confidential.

No official summary on file for this bill · generated by Gemini 2.5 Flash from its full text

Votes
Sponsorship · 2 Sponsors
Democrat0Republican2Independent0Other0
  • R · PrimeBen Keathley
  • R · CoBob Titus
Read full bill text →↓ Why am I seeing this?

Want updates?

Get notified when MO HB2081 moves stage

Pick a channel below. Every option is opt-in, and we tell you exactly what we store.

Email

Identified

We store your email address and the bill ID. We'll send a confirmation link first; alerts only start after you click it. Every email has a one-click unsubscribe.

Coming soon

  • RSS feed· Atom 1.0 + JSON Feed per bill
  • Bluesky· follow a CivicRadar bot post per status change
  • Telegram· channel or DM via bot
  • Discord· channel webhook
  • WhatsApp· via WhatsApp Business
  • SMS· via Twilio